argenx SE reported 288.02M in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
AstraZeneca USD 4.96B 127M Jun/2025
Galapagos EUR -158708000 177.84M Mar/2025
Genmab DKK 376M 172M Jun/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Qiagen NV USD 208.98M 38.23M Jun/2025
UCB EUR 1.37B 715M Dec/2024